of providing pharmaceuticals, ensuring staff salaries are paid, using USG partners to ensure continuity of treatment, , or any other activity to prevent treatment or service disruption. Public-Private Partnership(s) Created Partnership Related Mechanism Partner(s) PEPFAR USD Planned Funds USD Planned Funds PPP Description 2012 COP Private Sector Partnerships for Health (PSP4H) 14841:The HIV/AIDS Partnership: Impact through Prevention, Private Sector and (PIPPSE) PEPFAR/India has invested in many PPPs, demonstrating innovative models that contributed to achieving HIV-related goals in India, and that informed national dialogue on private sector engagement in the NACP. In FY12, PEPFAR/India builds on these successes through a new mechanism - to strengthen the GOI’s capacity to identify, attract and manage PPPs. The objectives of this
the IM PSP4H, and subsequently consolidated under the IM PIPPSE in the FY12 COP submission Surveillance and Survey Activities Surveillance or Survey Name Type of Activity Target Population Stage Expected Due Date N/A Adult and Pediatric Case Reporting - not PEPFAR funded AIDS/HIV Case Surveillance Pregnant Women Other N/A N/A ANC Sentinel Surveillance/PMTCT Sentinel Surveillance (e.g. ANC Surveys) Pregnant Women N/A N/A Behavioral Surveillance Behavioral Surveillance among MARPS Drug Users, Female Commercial Sex Workers, Injecting Drug Users, Male Commercial Sex Workers, Migrant Workers, Men who have Sex with Men Planning N/A N/A HIV Drug Resistance Surveillance - not PEPFAR funded HIV Drug Resistance Other Planning N/A N/A HIV Incidence Other Injecting Drug Users, Migrant Planning N/A
Workers, Men who have Sex with Men, Pregnant Women N/A India Demographic and Health Survey Behavioral Surveys General Population Planning N/A N/A Laboratory Support Other Other N/A N/A National Prevalence Estimates Other Other Planning N/A N/A Pediatric Surveillance - not PEPFAR funded Other Other N/A N/A Population size estimation Population size estimates Injecting Drug Users, Migrant Workers, Mobile Populations, Men who have Sex with Men, Other Other N/A N/A Surveillance Evaluation Evaluation Other Other N/A N/A TB/HIV Surveillance - not PEPFAR funded TB/HIV Other N/A N/A Vital Registration Sample Registration Survey HIV-mortality surveillance General Population Other N/A Budget Summary Reports Summary of Planned Funding by Agency and Funding Source
Policy Tracking Table Policy Area: Gender Policy: Mainstreaming HIV/AIDS for Women Empowerment Stages: Stage 1 Stage 2 Stage 3 Stage 4 Stage 5 Stage 6 Estimated Completion Date Narrative The purpose of these policy guidelines is to facilitate increased and improved action on the intersecting issues of HIV/AIDS and women by NACO, and all partners. The guidelines have been developed and framed in consultation with policy and programme personnel from the civil society including PLWH, women’s and the UN system. The policy may be periodically reviewed by a Committee comprising The guidelines were peer reviewed in 2007 and validated in April 2008 by experts on gender and HIV (Officials from NACO and SACS, senior government civil society partners, PLWH networks, and donor and UN agencies)
from the partners and civil society. Completion Date 2007 2008 Narrative Policy Area: Most at Risk Populations (MARP) Policy: National Migrant Intervention Strategy: Operational Guideline Stages: Stage 1 Stage 2 Stage 3 Stage 4 Stage 5 Stage 6 Estimated Completion Date 2007-08 2007-08 2007-08 2010 Narrative The purpose of these guidelines is to ensure the delivery of quality HIV prevention to highrisk populations. Migrants are at higher risk for HIV due to their high-risk behaviours. Over 30% of An important source of HIV-related vulnerability is mobility and migration. Migrant populations have higher levels of HIV infection than those who don't move. India, home to the 3rd highest number of NACO has prepared these Operational Guidelines after a series of with Technical Resource Groups (MARPs), of civil society, core groups, donors and NACO has rolled out the guidelines to scale up and improve the quality of HIV/AIDS migrant intervention intervention
the migrants at destination sites reported having sex with FSWs. HIV positive people in the world, is by widespread migration. Male migrants in India often migrate alone, leaving their wives and families behind, usually to work in the informal sector, which is unprotected and unregulated and accounts for 93% of total workforce in India. other USAID partner led the of the National Migrant Guidelines. Completion Date Narrative Policy Area: Orphans and Other Vulnerable Children Policy: Policy Framework for Children and AIDS
Stages: Stage 1 Stage 2 Stage 3 Stage 4 Stage 5 Stage 6 Estimated Completion Date 2012-13 Narrative The of India is committed to preventing HIV infection and mitigating the medical impact of the virus on the lives of those already infected. There is a need for a simple yet policy covering a broader agenda, spanning both the medical and dimensions of the epidemic as it affects children. The Policy Framework adopts a rights based approach. It takes into account recent changes in the global of the adverse impacts of HIV/AIDS on children, and of the best ways to address them. It is cognisant of advances in medical science. The first priority of this Policy is to prevent HIV infection, in order to ensure an AIDS-free generation. In addition to prompt diagnosis, the focus will also be to ensure access to treatment to prolong life. USG led the task force on Children affected by AIDS (CABA) in designing national operational guidelines. Following the launch of the Policy Framework for Children and AIDS further discussions with NACO and the Task Force Agencies for CABA led to of the approach for of the operational of CABA pilot scheme in ten districts of six states
Type 9195 Tamil Nadu AIDS Control Society Host Country Government Agency U.S. Department of Health and Human Services/Centers for Disease Control and Prevention GAP 1,000 9196 University of Manitoba University U.S. Agency for International Development GHP-USAID 0 9349 University of Washington University U.S. Department of Health and Human Services/Health Resources and Services Administration GHP-State 750,000 10085 SHARE India NGO U.S. Department of Health and Human Services/Centers for Disease Control and Prevention GAP, GHP-State 1,300,000 10964 APAC Private Contractor U.S. Agency for International Development GHP-USAID 0 10975 Avert Society NGO U.S. Agency for International Development GHP-USAID 0 10982 U.S. Department of Defense (Defense) Other USG Agency U.S. Department of Defense GHP-State 0 13196 Project Concern International NGO U.S. Department of Health and Human GHP-State, GAP 1,100,000
Services/Centers for Disease Control and Prevention 13387 FHI 360 NGO U.S. Department of Health and Human Services/Centers for Disease Control and Prevention GHP-State, GAP 1,100,000 13453 FHI 360 NGO U.S. Department of Health and Human Services/Centers for Disease Control and Prevention GAP, GHP-State 450,000 13527 TBD TBD Redacted Redacted Redacted 13573 FHI 360 NGO U.S. Agency for International Development GHP-USAID 2,500,000 13599 Social Impact Private Contractor U.S. Agency for International Development GHP-USAID 759,000 13604 TBD TBD Redacted Redacted Redacted 13642 TBD TBD Redacted Redacted Redacted 13649 TBD TBD Redacted Redacted Redacted 13711 TBD TBD Redacted Redacted Redacted 13810 International Labor Organization Multi-lateral Agency U.S. Department of Labor GHP-State 150,000 13887 TBD TBD Redacted Redacted Redacted 14088 UNAIDS II Multi-lateral Agency U.S. Department of Health and Human GHP-State 250,000
on cutting edge HIV and AIDS research and evidence-based case-management approaches; and identify complex issues related to managing HIV through case-specific clinical consultations. NDLCS also builds skill and experience in the use of the interactive webcasting distance learning technology that can be used to broaden its application for new audiences and purposes. In FY12, I-TECH-India will conduct 20 in-country NDLCS case-based instructional sessions on the clinical management of HIV via web cast to participants in all districts in India. Presenters for the series are national experts who have vast experience in the HIV field. Clinical and Programmatic Mentoring: One of the key components of I-TECH programs is mentoring. Clinical mentorship is a training and consultation system that fosters ongoing professional development and expertise to yield sustainable high quality clinical care outcomes. This practice supports decentralization of HIV care and standardizes antiretroviral therapy following national guidelines. In FY12, I-TECH will both mentor and provide mentoring training and other technical assistance to COE senior medical staff. Leveraging this supportive supervision model maximizes the knowledge and expertise of COE/ART clinicians. One senior NACO National Consultant will be supported by I-TECH. Implementing Mechanism Indicator Information Redacted Implementing Mechanism Details Mechanism ID: 10085 Mechanism Name: SHARE Funding Agency: U.S. Department of Health and Human Services/Centers for Disease Control and Prevention Procurement Type: Cooperative Agreement Prime Partner Name: SHARE India Agreement Start Date: Redacted Agreement End Date: Redacted TBD: No New Mechanism: N/A Global Fund / Multilateral Engagement: N/A G2G: N/A Managing Agency: N/A Total Funding: 1,300,000 Total Mechanism Pipeline: N/A Funding Source Funding Amount GAP 200,000 GHP-State 1,100,000
monitoring and ongoing assessment. 8. Provide technical support in data analysis and GIS for decision making and program implementation. 9. Provide technical support in strengthening capacities of program staff, state epidemiologists, M&E officers and other relevant staff involved in data generation, quality management and analysis. WHO/India is currently developing its 5-year Country Cooperation Strategy with GOI, stakeholders, civil society and development partners. The WHO’s specific plan of work under this Implementing Mechanism will be finalized based on this Cooperation Strategy. Implementing Mechanism Indicator Information Redacted Implementing Mechanism Details Mechanism ID: 14838 TBD: Yes REDACTED Implementing Mechanism Details Mechanism ID: 14839 TBD: Yes REDACTED Implementing Mechanism Details Mechanism ID: 14840 TBD: Yes REDACTED Implementing Mechanism Details Mechanism ID: 14841 TBD: Yes REDACTED
Non-ICASS Administrative Costs GHP-USAID 19,000 U.S. Department of Health and Human Services/Centers for Disease Control and Prevention Agency Cost of Doing Business GAP GHP-State GHP-USAID Central GHP-State Cost of Doing Business Category Total Capital Security Cost Sharing 270,000 36,000 306,000 Computers/IT Services 20,000 20,000 ICASS 210,000 210,000 Institutional Contractors 100,000 100,000 Non-ICASS Administrative Costs 255,200 55,000 310,200 Staff Program Travel 286,000 21,000 307,000 USG Staff Salaries and Benefits 985,992 43,638 1,029,630 Total 2,127,192 155,638 0 0 2,282,830 U.S. Department of Health and Human Services/Centers for Disease Control and Prevention Other Costs Details Category Item Funding Source Description Amount Capital Security Cost Sharing GAP 270,000 Capital Security Cost Sharing GHP-State 36,000 Computers/IT Services GAP 20,000 ICASS GAP 210,000 Non-ICASS GAP Transportation of 255,200